Exploiting chimeric human antibodies to characterize a protective epitope of Neisseria adhesin A, one of the Bexsero vaccine components
出版年份 2016 全文链接
标题
Exploiting chimeric human antibodies to characterize a protective epitope of Neisseria adhesin A, one of the Bexsero vaccine components
作者
关键词
-
出版物
FASEB JOURNAL
Volume 30, Issue 1, Pages 93-101
出版商
FASEB
发表日期
2015-08-25
DOI
10.1096/fj.15-273813
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Neisseria Adhesin A Variation and Revised Nomenclature Scheme
- (2014) Stefania Bambini et al. Clinical and Vaccine Immunology
- Structure of the meningococcal vaccine antigen NadA and epitope mapping of a bactericidal antibody
- (2014) Enrico Malito et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigen
- (2013) Enrico Malito et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural Insight into the Mechanism of DNA-Binding Attenuation of the Neisserial Adhesin Repressor NadR by the Small Natural Ligand 4-Hydroxyphenylacetic Acid
- (2012) Sébastien Brier et al. BIOCHEMISTRY
- Transcriptional Regulation of thenadAGene in Neisseria meningitidis Impacts the Prediction of Coverage of a Multicomponent Meningococcal Serogroup B Vaccine
- (2012) Luca Fagnocchi et al. INFECTION AND IMMUNITY
- Of Mice and Men: The Need for Humanized Mouse Models to Study Human IgG Activity in Vivo
- (2012) Anja Lux et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Combined Roles of Human IgG Subclass, Alternative Complement Pathway Activation, and Epitope Density in the Bactericidal Activity of Antibodies to Meningococcal Factor H Binding Protein
- (2011) Serena Giuntini et al. INFECTION AND IMMUNITY
- In the NadR Regulon, Adhesins and Diverse Meningococcal Functions Are Regulated in Response to Signals in Human Saliva
- (2011) L. Fagnocchi et al. JOURNAL OF BACTERIOLOGY
- Antibodies in oncology
- (2011) Vinochani Pillay et al. New Biotechnology
- Rational Design of a Meningococcal Antigen Inducing Broad Protective Immunity
- (2011) M. Scarselli et al. Science Translational Medicine
- Characterization of fHbp, nhba (gna2132), nadA, porA, and Sequence Type in Group B Meningococcal Case Isolates Collected in England and Wales during January 2008 and Potential Coverage of an Investigational Group B Meningococcal Vaccine
- (2010) J. Lucidarme et al. Clinical and Vaccine Immunology
- Structure and function of immunoglobulins
- (2010) Harry W. Schroeder et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Characterization of fHbp, nhba (gna2132), nadA, porA, Sequence Type (ST), and Genomic Presence of IS1301 in Group B Meningococcal ST269 Clonal Complex Isolates from England and Wales
- (2009) J. Lucidarme et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus
- (2009) Stefania Bambini et al. VACCINE
- Structural organization of NadAΔ351–405, a recombinant MenB vaccine component, by its physico-chemical characterization at drug substance level
- (2009) Claudia Magagnoli et al. VACCINE
- A Novel Phase Variation Mechanism in the Meningococcus Driven by a Ligand-Responsive Repressor and Differential Spacing of Distal Promoter Elements
- (2009) Matteo M. E. Metruccio et al. PLoS Pathogens
- Antibody Engineering Principles and Applications
- (2008) LiNa Loo et al. CANCER JOURNAL
- Intranasal immunization of mice with recombinant Streptococcus gordonii expressing NadA of Neisseria meningitidis induces systemic bactericidal antibodies and local IgA
- (2008) Annalisa Ciabattini et al. VACCINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now